Budd-Chiari syndrome natural history, complications and prognosis: Difference between revisions
Mazia Fatima (talk | contribs) |
Mazia Fatima (talk | contribs) |
||
Line 6: | Line 6: | ||
==Overview== | ==Overview== | ||
If left untreated, patients with Budd-Chiari syndrome have a high mortality rate.About 90% die within 3 years as the disease may progresss to develop intractable ascites with emaciation, gastrointestinal bleeding, and liver failure.Prognosis is generally good with treatment, and the 5 year survival rate of patients with treatment of Budd-Chiari syndrome is approximately 74 %.Poor prognostic factors include older age at diagnosis, chronic disease, severe liver failure and associated refractory ascites. | |||
==Natural History== | ==Natural History== |
Revision as of 14:43, 6 November 2017
Budd-Chiari syndrome Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Budd-Chiari syndrome natural history, complications and prognosis On the Web |
American Roentgen Ray Society Images of Budd-Chiari syndrome natural history, complications and prognosis |
FDA on Budd-Chiari syndrome natural history, complications and prognosis |
CDC on Budd-Chiari syndrome natural history, complications and prognosis |
Budd-Chiari syndrome natural history, complications and prognosis in the news |
Blogs on Budd-Chiari syndrome natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Overview
If left untreated, patients with Budd-Chiari syndrome have a high mortality rate.About 90% die within 3 years as the disease may progresss to develop intractable ascites with emaciation, gastrointestinal bleeding, and liver failure.Prognosis is generally good with treatment, and the 5 year survival rate of patients with treatment of Budd-Chiari syndrome is approximately 74 %.Poor prognostic factors include older age at diagnosis, chronic disease, severe liver failure and associated refractory ascites.